sodium lactate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
4202 72-17-3

Description:

MoleculeDescription

Synonyms:

  • sodium lactate
  • lacolin
  • lactic acid sodium salt
  • monosodium lactate
The sodium salt of racemic or inactive lactic acid. It is a hygroscopic agent used intravenously as a systemic and urinary alkalizer.
  • Molecular weight: 112.06
  • Formula: C3H5NaO3
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA:
  • ALOGS:
  • ROTB: None

Drug dosage:

None

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
March 22, 1971 FDA BAXTER HLTHCARE

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Death 834.56 32.33 423 3652 373958 63110989
Peritonitis bacterial 613.89 32.33 123 3952 4756 63480191
Peritonitis 455.26 32.33 122 3953 17032 63467915
Peritoneal dialysis complication 386.00 32.33 67 4008 1153 63483794
Fungal peritonitis 250.19 32.33 41 4034 488 63484459
Sepsis 189.08 32.33 119 3956 153004 63331943
Device interaction 184.19 32.33 28 4047 196 63484751
Ultrafiltration failure 104.19 32.33 17 4058 196 63484751
Encapsulating peritoneal sclerosis 102.41 32.33 18 4057 332 63484615
Peritoneal cloudy effluent 74.05 32.33 12 4063 132 63484815
Cardiac arrest 73.65 32.33 55 4020 92490 63392457
Cardiovascular disorder 66.75 32.33 26 4049 11786 63473161
Myocardial infarction 65.63 32.33 53 4022 99840 63385107
Hypervolaemia 64.50 32.33 33 4042 28380 63456567
Cardiac disorder 61.19 32.33 39 4036 50777 63434170
Cardiac failure 53.72 32.33 45 4030 89097 63395850
Cerebrovascular accident 50.08 32.33 47 4028 107977 63376970
Drug ineffective 49.56 32.33 5 4070 1044760 62440187
Gangrene 47.47 32.33 17 4058 6106 63478841
Bloody peritoneal effluent 44.99 32.33 7 4068 58 63484889
Marasmus 41.33 32.33 9 4066 516 63484431
Hypoglycaemia 39.67 32.33 32 4043 60033 63424914

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Peritonitis bacterial 825.52 30.79 190 5118 5920 34945703
Death 818.64 30.79 580 4728 397469 34554154
Peritonitis 515.43 30.79 161 5147 16204 34935419
Peritoneal dialysis complication 490.65 30.79 99 5209 1610 34950013
Fungal peritonitis 338.96 30.79 64 5244 719 34950904
Device interaction 144.99 30.79 30 5278 552 34951071
Myocardial infarction 122.59 30.79 119 5189 120966 34830657
Cardiac disorder 122.28 30.79 78 5230 43048 34908575
Encapsulating peritoneal sclerosis 115.98 30.79 25 5283 564 34951059
Cardiac failure 114.21 30.79 101 5207 91147 34860476
Ultrafiltration failure 113.96 30.79 20 5288 143 34951480
Gangrene 106.85 30.79 36 5272 4550 34947073
Cardiac arrest 90.66 30.79 91 5217 96068 34855555
Peritoneal cloudy effluent 86.64 30.79 16 5292 157 34951466
Noninfectious peritonitis 84.20 30.79 15 5293 118 34951505
Sepsis 83.69 30.79 114 5194 166447 34785176
Hypervolaemia 80.13 30.79 45 5263 19664 34931959
Cardiovascular disorder 63.94 30.79 31 5277 10025 34941598
Catheter site infection 58.96 30.79 20 5288 2577 34949046
Bloody peritoneal effluent 47.39 30.79 9 5299 104 34951519
Off label use 46.31 30.79 5 5303 419519 34532104
Peritoneal effluent abnormal 39.76 30.79 7 5301 51 34951572
Drug ineffective 36.62 30.79 12 5296 456739 34494884
Hernia 36.55 30.79 21 5287 9562 34942061
Cerebrovascular accident 35.01 30.79 53 5255 84758 34866865
Procedural pain 34.15 30.79 16 5292 4790 34946833
Blood glucose false positive 33.58 30.79 6 5302 48 34951575
Localised infection 31.41 30.79 24 5284 17563 34934060
Hypoglycaemia 31.31 30.79 40 5268 54600 34897023

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Peritonitis bacterial 1153.54 26.65 240 5916 9327 79728905
Peritonitis 638.36 26.65 184 5972 27852 79710380
Peritoneal dialysis complication 532.04 26.65 100 6056 2254 79735978
Death 526.08 26.65 394 5762 566120 79172112
Fungal peritonitis 360.42 26.65 64 6092 1036 79737196
Device interaction 261.41 26.65 46 6110 704 79737528
Encapsulating peritoneal sclerosis 178.63 26.65 34 6122 817 79737415
Sepsis 130.02 26.65 130 6026 269298 79468934
Cardiac arrest 126.04 26.65 105 6051 171991 79566241
Ultrafiltration failure 111.11 26.65 19 6137 243 79737989
Gangrene 107.06 26.65 36 6120 8928 79729304
Peritoneal cloudy effluent 106.22 26.65 19 6137 320 79737912
Myocardial infarction 83.45 26.65 86 6070 184043 79554189
Noninfectious peritonitis 77.86 26.65 14 6142 243 79737989
Cardiac disorder 71.92 26.65 51 6105 65706 79672526
Hypervolaemia 65.77 26.65 41 6115 42649 79695583
Blood glucose false positive 60.45 26.65 9 6147 43 79738189
Cardiac failure 58.96 26.65 66 6090 154776 79583456
Hypoglycaemia 56.28 26.65 53 6103 101541 79636691
Bloody peritoneal effluent 55.81 26.65 10 6146 170 79738062
Complication associated with device 55.28 26.65 27 6129 17469 79720763
Catheter site infection 53.37 26.65 20 6136 6775 79731457
Off label use 49.63 26.65 6 6150 907209 78831023
Drug ineffective 48.59 26.65 12 6144 1080901 78657331
Peritoneal effluent abnormal 39.01 26.65 6 6150 37 79738195
Pneumonia 36.76 26.65 123 6033 660123 79078109
Peritoneal disorder 36.66 26.65 9 6147 726 79737506
Diabetic complication 36.29 26.65 10 6146 1269 79736963
Abdominal distension 35.60 26.65 45 6111 119605 79618627
Hypotension 33.87 26.65 92 6064 440225 79298007
Haemodialysis 31.95 26.65 19 6137 18149 79720083
Procedural complication 30.36 26.65 14 6142 7969 79730263
Headache 29.80 26.65 7 6149 653765 79084467
Blood loss anaemia 29.33 26.65 17 6139 15481 79722751
Cerebrovascular accident 29.30 26.65 47 6109 155245 79582987
Arthralgia 28.38 26.65 5 6151 571798 79166434

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
CHEBI has role CHEBI:64049 pH control agents
CHEBI has role CHEBI:65255 food preservatives

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Hypokalemia indication 43339004
Hypokalemia Prevention indication
Brain damage contraindication 2470005
Anuria contraindication 2472002 DOID:2983
Tachyarrhythmia contraindication 6285003
Urinary tract obstruction contraindication 7163005 DOID:5200
Peptic ulcer contraindication 13200003 DOID:750
Chronic obstructive lung disease contraindication 13645005 DOID:3083
Hyperkalemia contraindication 14140009
Severe chronic ulcerative colitis contraindication 14311001
Myocardial infarction contraindication 22298006 DOID:5844
Ventricular tachycardia contraindication 25569003
Complete atrioventricular block contraindication 27885002
Toxic megacolon contraindication 28536002 DOID:1770
Atony of colon contraindication 29479008
Hyperthyroidism contraindication 34486009 DOID:7998
Acute hepatitis contraindication 37871000
Hypertensive disorder contraindication 38341003 DOID:10763
Complete trisomy 21 syndrome contraindication 41040004 DOID:14250
Achalasia of esophagus contraindication 45564002 DOID:9164
Chronic heart failure contraindication 48447003
Bradycardia contraindication 48867003
Acidosis contraindication 51387008
Paralytic ileus contraindication 55525008 DOID:8442
Peptic reflux disease contraindication 57643001
Congenital myotonia, autosomal dominant form contraindication 57938005
Acute nephropathy contraindication 58574008
Ulcerative colitis contraindication 64766004 DOID:8577
Arterial thrombosis contraindication 65198009
Drug AND/OR toxin-induced diarrhea contraindication 65979008
Arteriosclerotic vascular disease contraindication 72092001
Hyperchloremia contraindication 74450001
Spastic paralysis contraindication 78403003
Disturbance of salivary secretion contraindication 78948009
Third degree burn injury contraindication 80247002
Chronic idiopathic constipation contraindication 82934008
Oliguria contraindication 83128009
Hiatal hernia contraindication 84089009 DOID:12642
Kidney disease contraindication 90708001 DOID:557
Myasthenia gravis contraindication 91637004 DOID:437
Gastrointestinal obstruction contraindication 126765001
Autonomic dysreflexia contraindication 129618003
Bleeding contraindication 131148009
Partial atrioventricular block contraindication 195039008
Acute pancreatitis contraindication 197456007 DOID:2913
Myocardial dysfunction contraindication 233928007
Disease of liver contraindication 235856003 DOID:409
Hyporeninemic hypoaldosteronism contraindication 236464008
Bladder outflow obstruction contraindication 236645006
Pyloric obstruction contraindication 244815007
Benign prostatic hyperplasia contraindication 266569009
Retention of urine contraindication 267064002
Drowsy contraindication 271782001
Familial hyperkalemic periodic paralysis contraindication 304737009 DOID:14451
Hypoxia contraindication 389086002
Angle-closure glaucoma contraindication 392291006 DOID:13550
Gastric ulcer contraindication 397825006 DOID:10808
Chronic lung disease contraindication 413839001
Disorder of coronary artery contraindication 414024009
Hypertensive urgency contraindication 443482000
Azotemia contraindication 445009001
Severe dehydration contraindication 450316000




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
4018691 VUID
N0000147000 NUI
D02183 KEGG_DRUG
4018691 VANDF
C0142874 UMLSCUI
CHEBI:75228 CHEBI
CHEMBL1357 ChEMBL_ID
D019354 MESH_DESCRIPTOR_UI
4157 INN_ID
TU7HW0W0QT UNII
23666456 PUBCHEM_CID
56489 RXNORM
1084 MMSL
5487 MMSL
d00469 MMSL
000750 NDDF
000760 NDDF
015438 NDDF
387306001 SNOMEDCT_US
55015008 SNOMEDCT_US

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
Lactated Ringers HUMAN PRESCRIPTION DRUG LABEL 4 0264-2203 IRRIGANT 0.31 g IRRIGATION NDA 18 sections
Lactated Ringers HUMAN PRESCRIPTION DRUG LABEL 4 0264-2203 IRRIGANT 0.31 g IRRIGATION NDA 18 sections
Lactated Ringers HUMAN PRESCRIPTION DRUG LABEL 4 0264-2203 IRRIGANT 0.31 g IRRIGATION NDA 18 sections
Lactated Ringers HUMAN PRESCRIPTION DRUG LABEL 4 0264-2203 IRRIGANT 0.31 g IRRIGATION NDA 18 sections
Lactated Ringers Irrigation HUMAN PRESCRIPTION DRUG LABEL 4 0264-7389 SOLUTION 310 mg IRRIGATION NDA 14 sections
Lactated Ringers Irrigation HUMAN PRESCRIPTION DRUG LABEL 4 0264-7389 SOLUTION 310 mg IRRIGATION NDA 14 sections
Lactated Ringers HUMAN PRESCRIPTION DRUG LABEL 4 0264-7500 INJECTION, SOLUTION 0.31 g INTRAVENOUS NDA 23 sections
Lactated Ringers HUMAN PRESCRIPTION DRUG LABEL 4 0264-7500 INJECTION, SOLUTION 0.31 g INTRAVENOUS NDA 23 sections
Lactated Ringers HUMAN PRESCRIPTION DRUG LABEL 4 0264-7750 INJECTION, SOLUTION 0.31 g INTRAVENOUS NDA 23 sections
Lactated Ringers HUMAN PRESCRIPTION DRUG LABEL 4 0264-7750 INJECTION, SOLUTION 0.31 g INTRAVENOUS NDA 23 sections
Lactated Ringers HUMAN PRESCRIPTION DRUG LABEL 4 0264-7750 INJECTION, SOLUTION 0.31 g INTRAVENOUS NDA 23 sections
Lactated Ringers HUMAN PRESCRIPTION DRUG LABEL 4 0264-7750 INJECTION, SOLUTION 0.31 g INTRAVENOUS NDA 23 sections
Dextrose in Lactated Ringers HUMAN PRESCRIPTION DRUG LABEL 5 0264-7751 INJECTION, SOLUTION 0.31 g INTRAVENOUS NDA 22 sections
Lactated Ringers HUMAN PRESCRIPTION DRUG LABEL 4 0338-0114 IRRIGANT 310 mg IRRIGATION NDA 5 sections
Lactated Ringers HUMAN PRESCRIPTION DRUG LABEL 4 0338-0114 IRRIGANT 310 mg IRRIGATION NDA 5 sections
Lactated Ringers HUMAN PRESCRIPTION DRUG LABEL 4 0338-0114 IRRIGANT 310 mg IRRIGATION NDA 5 sections
Lactated Ringers HUMAN PRESCRIPTION DRUG LABEL 4 0338-0114 IRRIGANT 310 mg IRRIGATION NDA 5 sections
Lactated Ringers HUMAN PRESCRIPTION DRUG LABEL 4 0338-0117 INJECTION, SOLUTION 310 mg INTRAVENOUS NDA 19 sections
Lactated Ringers HUMAN PRESCRIPTION DRUG LABEL 4 0338-0117 INJECTION, SOLUTION 310 mg INTRAVENOUS NDA 19 sections
Lactated Ringers HUMAN PRESCRIPTION DRUG LABEL 4 0338-0117 INJECTION, SOLUTION 310 mg INTRAVENOUS NDA 19 sections
Lactated Ringers HUMAN PRESCRIPTION DRUG LABEL 4 0338-0117 INJECTION, SOLUTION 310 mg INTRAVENOUS NDA 19 sections
Lactated Ringers and Dextrose HUMAN PRESCRIPTION DRUG LABEL 5 0338-0125 INJECTION, SOLUTION 310 mg INTRAVENOUS NDA 18 sections
Lactated Ringers and Dextrose HUMAN PRESCRIPTION DRUG LABEL 5 0338-0125 INJECTION, SOLUTION 310 mg INTRAVENOUS NDA 18 sections
Lactated Ringers and Dextrose HUMAN PRESCRIPTION DRUG LABEL 5 0338-0125 INJECTION, SOLUTION 310 mg INTRAVENOUS NDA 18 sections
Lactated Ringers and Dextrose HUMAN PRESCRIPTION DRUG LABEL 5 0338-0125 INJECTION, SOLUTION 310 mg INTRAVENOUS NDA 18 sections
Lactated Ringers HUMAN PRESCRIPTION DRUG LABEL 4 0338-0137 IRRIGANT 3.10 g IRRIGATION NDA 17 sections
Lactated Ringers HUMAN PRESCRIPTION DRUG LABEL 4 0338-0137 IRRIGANT 3.10 g IRRIGATION NDA 17 sections
Lactated Ringers HUMAN PRESCRIPTION DRUG LABEL 4 0338-0137 IRRIGANT 3.10 g IRRIGATION NDA 17 sections
Lactated Ringers HUMAN PRESCRIPTION DRUG LABEL 4 0338-0137 IRRIGANT 3.10 g IRRIGATION NDA 17 sections
Dextrose and Electrolyte No. 48 HUMAN PRESCRIPTION DRUG LABEL 6 0338-0143 INJECTION 260 mg INTRAVENOUS NDA 19 sections